Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Immunity|April 12, 2015
Homeostatic NF-κB Signaling in Steady-State Migratory Dendritic Cells Regulates Immune Homeostasis and ToleranceMyriam Baratin, Chloe Foray, Olivier Demaria, et al.
The Journal of Clinical Investigation|September 3, 2010
TLR8 deficiency leads to autoimmunity in miceOlivier Demaria, Philippe P Pagni, Stephanie Traub, et al.
JCI Insight|January 12, 2023
Type I IFNs link skin-associated dysbiotic commensal bacteria to pathogenic inflammation and angiogenesis in rosaceaAlessio Mylonas, Heike C Hawerkamp, Yichen Wang, et al.
Nature Immunology|July 15, 2020
The commensal skin microbiota triggers type I IFN-dependent innate repair responses in injured skinJeremy Di Domizio, Cyrine Belkhodja, Pauline Chenuet, et al.
Plos Pathogens|February 13, 2008
Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1Suzana P Salcedo, María Ines Marchesini, Hugues Lelouard, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2015
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunityOlivier Demaria, Aude De Gassart, Sanja Coso, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2010
TLR3 and Rig-like receptor on myeloid dendritic cells and Rig-like receptor on human NK cells are both mandatory for production of IFN-gamma in response to double-stranded RNAIvan Perrot, Florence Deauvieau, Catherine Massacrier, et al.
The Journal of Allergy and Clinical Immunology|November 27, 2015
IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammationFlorence Fellmann, Federica Angelini, Jacqueline Wassenberg, et al.
Nature|July 30, 2020
Association of COVID-19 inflammation with activation of the C5a-C5aR1 axisJulien Carvelli, Olivier Demaria, Frédéric Vély, et al.
Critical Care Medicine|October 11, 2022
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE])Julien Carvelli, Ferhat Meziani, Jean Dellamonica, et al.
Pageof 4